Select Medical Holdings (SEM) Capital Expenditures (2018 - 2026)

Select Medical Holdings (SEM) has 9 years of Capital Expenditures data on file, last reported at $58.9 million in Q1 2026.

• Capital Expenditures for Q1 2026 came in at $58.9 million, up 12.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $235.8 million (up 991.29% YoY), and the FY2025 annual result was $229.2 million, up 952.26% from the prior year.
• Capital Expenditures was little changed at $58.9 million in Q1 2026 per SEM's latest filing, from $59.1 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $64.7 million in Q2 2025 and troughed at -$137.0 million in Q4 2024.
• A 5-year average of $42.9 million and a median of $53.1 million in 2025 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2024 and 2025: Capital Expenditures sank 326.0% in 2024, then surged 143.15% in 2025.
• A 5-year view of Capital Expenditures shows it stood at $55.3 million in 2022, then increased by 9.68% to $60.6 million in 2023, then slumped by 326.0% to -$137.0 million in 2024, then surged by 143.15% to $59.1 million in 2025, then dropped by 0.34% to $58.9 million in 2026.
• Business Quant data shows SEM's Capital Expenditures at $58.9 million in Q1 2026, $59.1 million in Q4 2025, and $53.1 million in Q3 2025.